Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More

Boston Scientific resumes enrolment in pulsed field ablation trial

Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations”. The trial – which tests Boston ... Read More

Boston Scientific resumes Farapulse pulsed field ablation study in ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ... Read More

Boston Scientific gets expanded PFA label for persistent AFib

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible for treatment with the Farapulse pulsed field ablation system. Read More

FDA approves expanded indication of pulsed field ablation systems for persistent AF

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes treatment of drug refractory, symptomatic persistent atrial fibrillation.The ... Read More

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation ... Read More

Boston Scientific Pauses Enrollment In Farapulse Study In ... - Benzinga

In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first ... Read More

Boston Scientific's CMO takes the pulse of pulsed field ablation

Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has seen its Farapulse sales grow by leaps and bounds. Last week, during ... Read More

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

The rate of direct current cardioversion declined from 4.5% in the 6 months prior to study enrollment to 0. ... DiNovA EP Technology, East End Medical, EPD Philips, EP Frontiers, Epix ... Read More

Globe Device Touted as Advance for Pulsed Field Ablation

In the single-arm PULSAR IDE study of 162 people, the novel PFA system demonstrated 78% primary effectiveness, defined as 12-month freedom from a documented 30-second episode of Afib/atrial ... Read More